Floatz logo

[ 18f]3f4ap

Spinal Cord Injury

Yale UniversityradiopharmaceuticalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Spinal Cord Injury cohort.

Asset / SponsorPhaseRating
Pregabalin
Ju Seok Ryu
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
MetroHealth Medical Center
Phase 4BB
VENLOR
University of Washington
Phase 4BB
Semaglutide
James J. Peters Veterans Affairs Medical Center
Phase 4BB
Brivaracetam
University of Minnesota
Phase 3BB

View all 42 →

Same molecule, other indications

[ 18f]3f4ap is also rated in:

Alzheimer diseaseDormant
CC
Indicative ·
43 / 100
View asset →
demyelinating diseaseDormant
CC
Indicative ·
43 / 100
View asset →
traumatic brain injuryDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →